Clinical Trials Insight: 700040526
Phase of Trial: Phase I
Latest Information Update: 02 Jul 2009
At a glance
- Drugs Auriclosene (Primary)
- Indications Bacterial infections; Ophthalmic infections
- Focus Therapeutic Use
- Sponsors Alcon
- 02 Jul 2009 Status changed from planning to recruiting as reported by NovaBay.
- 15 Jan 2009 New trial record.